Safe Injection Sites: Existing Evidence and Implications for Massachusetts by unknown
The Graduate Review 
Volume 5 Article 10 
2020 
Safe Injection Sites: Existing Evidence and Implications for 
Massachusetts 
Follow this and additional works at: https://vc.bridgew.edu/grad_rev 
 Part of the Social Work Commons 
Recommended Citation 
(2020) Safe Injection Sites: Existing Evidence and Implications for Massachusetts. The Graduate Review, 
5, 47-59. 
Available at: https://vc.bridgew.edu/grad_rev/vol5/iss1/10 
This item is available as part of Virtual Commons, the open-access institutional repository of Bridgewater State 
University, Bridgewater, Massachusetts. 
Copyright © 2020 








The opioid epidemic has been characterized as a national public health crisis impacting individuals throughout the United States. 
Unintended overdose deaths have increased by 
21% from 2014-2016, with 63,300 people dying 
from overdoses in 2016. To respond to this epi-
demic, health professionals have begun to consid-
er the implementation of safe injection sites (SIS) 
in many major cities throughout the United States. 
Opioids, “refer to a family of substances that in-
clude natural opiates like morphine and codeine, 
as well as synthetic and semi-synthetic opioids like 
Heroin, Oxycodone and Fentanyl” (The Massa-
chusetts Opioid Epidemic: A Data Visualization of 
Findings from the Chapter 55 Report, n.d.). These 
drugs have been used by medical professionals 
to treat different forms of pain, including “acute 
post-surgical pain, chronic pain in cancer patients, 
and end-of-life care” (The Massachusetts Opioid 
Epidemic: A Data Visualization of Findings from 
the Chapter 55 Report, n.d.). The use of opioids 
becomes problematic when used inappropriately, 
resulting in addiction and overdose. Overdoses as 
a result of opioid use have seen a strikingly large 
increase throughout the United States in recent 
years and have sparked polarizing conversations 
surrounding appropriate and effective interven-
tions for individuals impacted. 
Overview of the Problem
Unintended overdose death rates as a result 
of the rising opioid epidemic have continued to 
increase, with over 70,000 unintended overdoses 
recorded in 2017 (Center for Disease Control and 
Prevention, 2018). On a national level, the Center 
for Disease Control and Prevention (CDC) reports 
130 people die from an opioid overdose every day 
(Center for Disease Control and Prevention, 2019). 
While this has been a source of national attention, 
it has been a specific concern for the Common-
wealth of Massachusetts, where it has been found 
that opioid death rates are significantly higher than 
the national average (Massachusetts Department 
of Public Health, 2017). The Massachusetts opi-
oid-related overdose death rate in 2017 was 28.2 
deaths per 100,000 persons, with the national rate 
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at 14.6 deaths per 100,000 persons (National Insti-
tute on Drug Abuse, 2019). According to the Chap-
ter 55 Report, this is the first time Massachusetts 
has seen such a drastic increase in a single catego-
ry of deaths since the AIDS epidemic in the late 
1990s (Baker, Polito, Sudders, & Bharel, 2017). 
Overdose deaths are some of the highest 
priority concerns relating to the opioid epidemic, 
but it is not the only way this epidemic impacts 
this population. As opioid use continues to rise, 
there has also been a 249% increase in Hepatitis 
C diagnoses (Center for Disease Control and Pre-
vention, 2019). In addition, 1 in every 10 new HIV 
infections are among people who inject drugs; and 
the MRSA infection rate has increased by 124% 
between 2011 and 2016 among people who inject 
drugs (Center for Disease Control and Preven-
tion, 2019). Therefore, there are not only concerns 
about overdose deaths, but the spread of infectious 
diseases is another high priority issue as a result of 
this epidemic. 
Impacted Populations 
In Massachusetts, opioid-related overdose 
deaths have an expansive impact with the 1,995 
confirmed opioid-related overdose deaths (Massa-
chusetts Department of Public Health, 2019). At 
this rate, Massachusetts has been ranked among 
the top 10 states with the highest rates of over-
dose deaths involving opioids (Center for Disease 
Control and Prevention, 2018). An important note 
that is unique about the impact of opioids is that 
it is prevalent among all races, classes, genders, 
and geographical locations (Massachusetts De-
partment of Public Health, 2017). In fact, almost 
every community and demographic of people have 
been impacted by opioid use. Despite the expan-
siveness of opioid addiction, The Executive Office 
of Health and Human Services published a report 
including specific groups of people considered to 
be of higher risk. These demographics included 
the homeless, formerly incarcerated, the mental-
ly ill, younger males, and the White Non-Hispanic 
population (Baker et al., 2017).
Figure 1
The Massachusetts Opioid Epidemic
(n.d., para. 4)
Figure 1 
The Massachusetts Opioid Epidemic (n.d, para. 4) 
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According to this report, risk of opioid-re-
lated overdose is 120 times higher for individuals 
released from prisons and jails, 30 times higher for 
the homeless population, 6 times higher for a per-
son diagnosed with a serious mental illness, and 3 
times higher for individuals living with depression 
(Baker et al., 2017).
In light of the evidence explaining the 
scope of this social problem, it has been impera-
tive that government representatives actively work 
to propose effective solutions to combat this epi-
demic. SIS have been considered a harm-reduction 
model proposed as a solution to reduce overdose 
deaths and the spread of infection and disease. 
This harm-reduction model has received an im-
mense amount of both support and backlash, thus 
preventing these sites from being implemented 
throughout Massachusetts. 
The History of Safe Injection Sites
SIS are spaces where people living with ad-
diction can safely administer pre-obtained drugs 
(Barry, Sherman, Stone, Kennedy-Hendricks, 
Niederdeppe, Linden, & McGinty 2019). They 
are hygienic, dignified environments, staffed with 
emergency response professionals to prevent over-
dose and provide education surrounding safe in-
jection practices (Lefor, 2019). SIS also connect 
individuals struggling with addiction to a variety 
of health, mental health, and community-based 
services (Barry et al., 2019). A vast amount of ev-
idence has suggested that SIS succeed in reducing 
overdose deaths, increasing participation in drug 
treatment programs, and decreasing intravenous 
drug use in public (Beletsky, Davis, Anderson, & 
Burris, 2008). Despite empirical evidence, SIS re-
main illegal in the United States as policymakers 
have been resistant to supporting them. Until re-
cently, the thought of implementing SIS was con-
sidered to be prohibited in the U.S. (Kreit, 2019). 
Harm-reduction measures such as SIS were con-
sidered to be in conflict with the war on drugs and 
were viewed by policymakers as an act of capit-
ulation (Kreit, 2019). Views on this matter began 
to shift within the past decade, after the 52,000 
drug overdose deaths that occurred in 2015 (Kreit, 
2019). The United States is currently described to 
be experiencing one of the worst drug crises in its 
history (Kreit, 2019).
Progressive steps taken in Massachu-
setts include efforts to end the stigma. This was 
addressed by the Department of Public Health, 
launching the State Without StigMA campaign, 
promoting the Good Samaritan Law, and reassur-
ing individuals that they will not be charged with 
possession of a substance if they call 911 regarding 
an overdose. Other responsive steps in Massachu-
setts include prescription monitoring and prescrip-
tion drug training (Massachusetts Department of 
Public Health, 2017). Although SIS are still illegal 
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in the United States, policy officials have become 
willing to learn more about this harm-reduction 
model. SIS remain a highly controversial topic and 
continue to mainly be viewed as a risk to the safety 
of the surrounding community, with illegal sites 
that would enable drug use and other dangerous 
behaviors.
An Act Relative to
Supervised Injection Facilities
In January of 2019, Bill S.1134, An Act Relative to 
Supervised Injection Facilities, was introduced to 
the 191st General Court of the Commonwealth of 
Massachusetts. The Bill was petitioned by Senator 
Boncore and Representatives Lewis and Sabado-
sa. The proposed Bill requested the Department of 
Public Health to study the potential usefulness of 
supervised SIS. The Department of Public Health 
intends to further research the current impacts of 
public safety and health when implementing SIS 
as an intervention in communities and with indi-
viduals who are struggling with addiction (An Act 
Relative to Supervised Injection Facilities, 2019).
Stakeholders’ Stances
The Department of Public Health will be 
evaluating the feasibility of SIS. The findings 
from this evaluation must be presented in July 
of 2020 (An Act Relative to Supervised Injection 
Facilities, 2019). SIS have not been endorsed by 
President Donald Trump’s Opioid and Drug Abuse 
Commission at this time (Minhee & Calandrillo, 
2019). The Department of Justice has also not sup-
ported SIS or proposed pilot programs to gain ev-
idence-based research. In addition, Massachusetts 
Governor Charles Baker has publicly announced 
that he fully supports the Federal Government’s 
current stance on SIS and does not support legal-
izing SIS in Massachusetts at this time (Markos, 
2019). 
However, significant medical organizations 
such as the U.S. Surgeon General and the Ameri-
can Medical Association have been in support of 
safe injection programs (Minhee & Calandrillo, 
2019). The Centers for Disease Control and Pre-
vention and the National Institutes of Health addi-
tionally are other significant stakeholders support-
ing more research on the efficacy of SIS (Beletsky 
et al., 2008). Despite the federal government cau-
tioning criminal prosecution, cities such as Seattle, 
San Francisco, New York City, Philadelphia, and 
Baltimore have all reported intentions of opening 
SIS (Minhee & Calandrillo, 2019).
Legal Implications
A major barrier to the implementation of 
SIS is the direct conflict with federal drug policies. 
The Federal Controlled Substance Act Section 
844 prohibits all drug possession (Beletsky et al., 
2008). Section 856, also known as the “Crack 
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House Statute”, makes it illegal to knowingly 
“open, maintain, manage or control any place for 
the purpose of unlawfully using a controlled sub-
stance” (Beletsky et al., 2008, p. 234). 
The current laws in place make SIS illegal 
anywhere in the United States. If a city were to 
open a SIS, the staff of the program would be at 
risk of facing criminal charges, which could po-
tentially result in a federal prison sentence (Kreit, 
2019). The following proposal by advocates for 
SIS has been suggested to restructure the “Crack 
House Statute”. First, advocates suggest the courts 
limit the “Crack House Statute” so that it would 
not apply for SIS. Second, they would advocate 
for creating a “federalism-based defense of safe in-
jection facilities’’ (Kreit, 2019, p. 433). And lastly, 
they would recommend approving a non-enforce-
ment policy, protecting SIS and allowing commu-
nities to proceed in opening them, despite being 
illegal (Kreit, 2019). By restructuring the “Crack 
House Statute”, substance abuse treatment provid-
ers would be granted protection, allowing them to 
open SIS. 
SIS could technically be approved through 
a town mayor, local health commissioner, com-
munity agency, or city council, depending on the 
structure of the local government (Kreit, 2019). 
Approved SIS at the local level are described by 
Kreit (2019) to be a weaker approach. A locally 
authorized SIS would have less protection against 
police interference and would likely be challenged 
by the government for conflicting with state law 
(Beletsky et al., 2008).
A state government may authorize SIS 
through administrative action by the executive 
branch. However, state authorization cannot re-
voke federal drug laws. Therefore, it does not pro-
tect SIS against being shut down by federal law 
enforcement agencies (Beletsky et al., 2008). Bill 
S.1134 is allowing the Massachusetts Department 
of Public Health to conduct research and study the 
feasibility of SIS in Massachusetts.
Statistical Significance
There has been an increase in opioid-relat-
ed overdoses, fatal and nonfatal, in the Common-
wealth of Massachusetts. According to the most 
recent data brief in 2017, the estimated percentage 
of the Massachusetts population with opioid-use 
disorder is 4.4% (Massachusetts Department of 
Public Health, 2017). Nonfatal overdoses were re-
ported to have increased 200% from 2011-2015, 
bringing the total number of nonfatal overdoses 
between 2011 and 2015 to exceed 65,000 (Massa-
chusetts Department of Public Health, 2017). Six 
point two percent of individuals in the Massachu-
setts Department of Public Health’s Data Brief in 
2017 had a fatal opioid-related overdose within 
one year following their initial overdose, and a to-
tal of nine point three percent of the individuals 
52 • The Graduate Review • 2020 Bridgewater State University
studied experienced a fatal opioid-related over-
dose two years after their initial non-fatal over-
dose (Massachusetts Department of Public Health, 
2017). In the first nine months of 2019, there were 
a total of 1,091 confirmed opioid-related overdose 
deaths. Numbers were expected to continue to rise 
by the end of the year (Massachusetts Department 
of Public Health, 2019).
There are currently over 100 SIS in Cana-
da, Australia, and parts of western Europe. For the 
past 15 years, Switzerland has had SIS and has not 
had one opiate overdose since opening. In addition, 
Canada has utilized SIS for over 15 years and has 
never experienced any overdoses or on-site deaths 
(Beletsky et al., 2008). Research in these countries 
has found SIS to be an effective intervention that 
reduces the overall harm that the opioid epidem-
ic has on individuals struggling with addiction. A 
multitude of evidence-based studies throughout 
these countries have found that SIS are associated 
with reduced overdose deaths, reduced life-threat-
ening infections, decreased syringe sharing, and de-
creased emergency room hospital visits (Beletsky 
et al., 2008). SIS are also reported to have commu-
nity benefits; they have been found to reduce the 
amount of drug use within communities and reduce 
the number of discarded syringes and drug-related 
litter within the community (Beletsky et al., 2008). 
Despite current research, there is a need for in-
creased evidence-based research within the U.S. to 
further determine the effectiveness of SIS.
 
Supporting Arguments
SIS have been an extremely controversial 
solution proposed to respond to the opioid epidem-
ic. There is a continued debate surrounding the ef-
fectiveness and impact this type of facility would 
have on individuals who use drugs, the surround-
ing community, and the opioid epidemic in gen-
eral. Those who are in favor of implementing SIS 
are hopeful based on the positive outcomes that 
have been found in other countries using SIS as a 
harm-reduction model. Alternatively, those against 
SIS are hesitant because of the potential negative 
effects this harm-reduction model could spark.
Despite various initiatives, including 
clinical prescribing guidelines, dosing regulations, 
the establishment of prescription drug monitoring 
programs, “pill mill” crackdowns, and insurance/
regulatory changes to broaden access to addiction 
treatment, the opioid epidemic has continued to 
expand (Barry et al., 2019). This has led support-
ers of SIS to believe, “new approaches are needed 
beyond just monitoring prescriptions of opioids as 
synthetic versions are rising” (Barry et al., 2019, p. 
19). Research carried out in various countries have 
found SIS to be a best practice intervention to re-
duce the overall harm the opioid epidemic has on 
individuals who use drugs and on the surrounding 
communities. There are both individual benefits 
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for people using drugs who could access SIS, and 
community-level benefits for areas where drug use 
has been problematic. 
Based on previous research, supporters of 
SIS believe that these facilities will reduce over-
dose deaths by providing safe spaces staffed by 
medical professionals. A study carried out at an 
undercover safe injection site operating in the 
United States found this to be true after the room 
was used 4,623 times within 3 years (Davidson, 
Lopez, & Kral, 2018). Despite there being six 
overdoses at this facility, all six individuals were 
able to be successfully revived, and there were no 
overdose deaths (Davidson et al., 2018). In addi-
tion, clean needles provided at SIS would reduce 
syringe sharing and reuse of dirty needles and, in 
turn, are expected to reduce HIV and Hepatitis C 
infections among this population (Barry, Sherman, 
& McGinty, 2018; Potier, Laprévote, Dubois-Ar-
ber, Cottencin, & Rolland, 2014). 
Supporting arguments would also debate 
that these are not solely places to safely use drugs, 
but SIS are a gateway to reach the vulnerable pop-
ulation of opioid users and connect them to a va-
riety of health care services, social services, and 
general safety education they would not otherwise 
receive (Davidson et al., 2018; Potier et al., 2014). 
The same study carried out at the undercover SIS 
in the United States surveyed individuals who used 
the facility and found that users’ requests for edu-
cation on vein care and connection to health and 
mental health services increased after using the 
facility regularly (Davidson et al., 2018). Lastly, 
drug users participating in the study also reported a 
decreased impact of stigma and increased feelings 
of peace, understanding, and respect once they no 
longer had to find ways to use in public spaces 
within their community (Davidson et al., 2018). 
Increasing the dignity and respect of people living 
with opioid addiction and understanding addiction 
as a disease in need of multifaceted interventions 
beyond just abstinence is a foundational argument 
for activists supporting a Bill for SIS. 
In addition to the benefits SIS have for 
individual drug users and their overall health, there 
are also positive community-level consequences 
that defend the efficacy of these facilities. Research 
shows that SIS reduce the amount of public drug 
use in communities, in addition to reducing the 
amount of public disposal of needles (Potier et 
al., 2014). In one study, there was a 69% decrease 
in syringe sharing after the establishment of a 
SIS (Potier et al., 2014). Each of the data points 
mentioned has been used in support of SIS and ex-
ist as intended consequences supported by empir-
ical research.
Opposing Arguments and 
Unintended Consequences
A study that surveyed Americans found that 
54 • The Graduate Review • 2020 Bridgewater State University
only 29% of people are in support of legalizing SIS 
(Barry et al., 2018). A variety of influences contrib-
ute to shaping the beliefs of those who oppose SIS 
including the media, newspapers, advocacy sites, 
powerful public figures, and community leaders- 
some of whom were previously mentioned as rel-
evant stakeholders. Various researchers through-
out the United States and Canada have used polls, 
focus groups, and individual interviews to collect 
information about the reasons why public support 
is lacking for this type of facility (Kolla, Strike, 
Watson, Jairam, Fischer, & Bayoumi, 2017). The 
central opposing arguments positioned against SIS 
can be categorized as individual-level arguments, 
concerned with the impact on people who use 
drugs, and community-level arguments, concerned 
with the impact on the surrounding community. 
An individual argument present in the de-
bate about SIS is that creating spaces for individu-
als to use drugs without fear of legal ramifications 
would enable the use and encourage dangerous be-
haviors (Kolla et al., 2017). It has been stated that 
it would increase the number of people who use 
illegal drugs, or how often illegal drugs are used, 
because SIS make it easier to use illegal drugs 
(Kolla et al., 2017). Not only is it argued that SIS 
will increase illegal drug use, but it is also believed 
that it will increase other dangerous, harmful, and 
illegal behaviors or activities (Kolla et al., 2017). 
In one survey, 58% of respondents believed that 
funding would be better spent on opioid treatment 
centers, working to end addiction as opposed to 
the development of SIS (Barry et al., 2018).
One of the main community-level argu-
ments opposing SIS proposes that drug use is ille-
gal in the United States, and therefore SIS would 
undermine the stance of the federal government 
and the laws that were put in place as a means 
of protection. Many believe that the government 
should continue to take a zero-tolerance stance on 
drug use, and violators deserve punishment (Barry 
et al., 2018). Similarly, there is also concern that if 
the government chose to turn a “blind eye” to ille-
gal drug use within SIS, it would send the wrong 
message and condone drug use for younger gener-
ations (Kolla et al., 2017). 
Another community-level argument against 
SIS is that opening them would draw people who 
sell and use illegal drugs to spend more time in 
the area (Kolla et al., 2017). Many debate that this 
would increase drug use, drug dealing, crime, and 
public disorder, decreasing safety for community 
members (Kolla et al., 2017). As a result, there is a 
concern that an unintended impact of SIS would be 
that increased crime and drug use would decrease 
property value and business profits in communi-
ties where SIS are established (Kolla et al., 2017). 
These changes in property and business value may 
result from a change in perception of the level of 
safety within the community and prevent people 
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from wanting to visit or purchase property in the 
area (Kolla et al., 2017). While most empirical re-
search does not support this concern, it is import-
ant to note a study carried out in Germany/Neth-
erlands found that just under half of the 15 SIS 
opened did experience an increase in drug dealing 
and a one-fifth increase in petty crimes (Kolla et 
al., 2017). While this is not generalizable or rep-
resentative of all SIS, it must be noted that it has 
happened. 
The last major concern expressed by stake-
holders opposing SIS is the lack of impartial evi-
dence assessing the impact on the surrounding com-
munity. It has been argued that research is overly 
focused on combating individual health risks for 
people who use drugs and has not taken into con-
sideration the potential development of communi-
ty-level risk factors and unintended consequences 
(Kolla et al., 2017). More research focusing solely 
on community-level impacts of SIS would need to 
be carried out to determine if there are unintended 
impacts that have not been identified yet. 
Recommendations
An Act Relative to Supervised Injection 
Facilities (Bill S.1134) has been referred to the 
Committee on Mental Health, Substance Use, and 
Recovery. The commissioner of public health will 
release the results from the feasibility study to the 
Chairs of the Joint Committee on Mental Health, 
Substance Use, and Recovery; the Chairs of the 
Joint Committee on Public Health; the Chairs 
of the Joint Committee on the Judiciary; and the 
Chairs of the Senate and House Committees. Re-
sults must be provided on or before July 31, 2020 
(An Act Relative to Supervised Injection Facilities, 
2019). On October 1, 2019, testimonies from state 
representatives, executive officeholders, and citi-
zens who have experienced the opioid crisis first-
hand were heard. The Committee had until April 
15, 2020 to move Bill S.1134 out of committee 
(Smith, 2019).
After reviewing the scope of the opioid epi-
demic, the background and research existing about 
SIS, and the different sides of the debate, this pol-
icy analysis will conclude with recommendations 
for change. There is currently evidence and reason 
to believe that SIS could be a part of the solution for 
the increasing number of overdose deaths and the 
spread of disease as a result of the opioid epidemic. 
Therefore, it is recommended that the Federal Sub-
stance Abuse Act be amended to allow state gov-
ernments the discretion to authorize SIS through 
administrative action without legal repercussions. 
Currently, this is the biggest barrier to change be-
cause the Massachusetts government cannot autho-
rize any pilot programs to determine the effective-
ness of SIS throughout Massachusetts without a 
chance of federal repercussions, if there continues 
to be a federal law prohibiting these actions.
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Once accomplished, it is recommended that 
Massachusetts open pilot programs throughout 
major cities, closely tracking data correlated with 
both individual outcomes and the impact on the 
community to determine the effectiveness of SIS 
in Massachusetts.
Another barrier to this change is the stigma 
that skews voters’ understanding of opioid addic-
tion as a disease, leading individuals to have neg-
ative views about opioid users (Johnson, 2018). In 
light of this, the final recommendation to combat 
this would be to increase federal- and state-level 
funding to support organizations working to end 
the stigma and educate community members on 
addiction as a disease rather than a moral failing 
(Johnson, 2018). Increasing the number of voters 
informed more by research than stigma, could po-
tentially increase public support and encourage 
Massachusetts state officials to support state-wide 
efforts to implement harm-reduction models in re-
sponse to the opioid epidemic. 
Conclusion
As displayed throughout this brief and 
analysis, SIS continue to be a polarizing topic 
throughout Massachusetts and the United States, in 
general. While many disagree upon what the most 
effective and ethical solution is to this problem, the 
statistics surrounding the rate of opioid deaths in 
Massachusetts alone are a cause of immense con-
cern. The implementation of SIS in Massachusetts 
is supported by empirical research carried out in 
countries that have effectively implemented these 
programs and have seen positive outcomes. Alter-
natively, it is important to consider the potential 
negative impacts on both individuals and commu-
nities that could result from this harm-reduction 
model. While both sides of this debate have valid 
points, further research is the most promising solu-
tion to provide concrete answers to unanswered 
questions. The research recommended in Bill 
S.1134 will continue to push the conversation for-
ward and help stakeholders, government officials, 
and addiction professionals collaborate to deter-
mine if this is an effective harm-reduction model 
that should be advocated for on the federal level, 
and ultimately implemented in Massachusetts.
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